ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,528Medicare Part D Prescriptions Filled, Including Refills

Rank: 59 out of 2588

$1.07M Total Retail Price of All Prescriptions

Rank: 76 out of 2588

634 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 634 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 634 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 17,329 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 1,096 884 1 2
LISINOPRIL 908 801 2 3
FUROSEMIDE 653 555 3 5
POTASSIUM CHLORIDE 609 579 4 15
SIMVASTATIN 604 501 5 1
CITALOPRAM HBR 595 498 6 27
METOPROLOL TARTRATE 559 499 7 9
HYDROCODONE-ACETAMINOPHEN 551 398 S3 8 7
OMEPRAZOLE 489 351 9 6
WARFARIN SODIUM 487 456 10 10
NAMENDA 415 403 11 32
METFORMIN HCL 410 314 12 8
DONEPEZIL HCL 354 354 13 22
HYDROCHLOROTHIAZIDE 339 254 14 13
METOPROLOL SUCCINATE 281 270 15 12
AMLODIPINE BESYLATE 258 241 16 4
ZOLPIDEM TARTRATE 254 204 17 24
POLYETHYLENE GLYCOL 3350 245 229 18 55
CARVEDILOL 227 212 19 20
ALLOPURINOL 216 184 20 33
CYMBALTA 210 153 21 70
ATORVASTATIN CALCIUM 200 156 22 11
ATENOLOL 196 171 23 14
GABAPENTIN 188 167 24 18
ISOSORBIDE MONONITRATE ER 184 184 25 49
TRAMADOL HCL 184 162 25 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 183 157 27 35
CLOPIDOGREL 179 146 28 30
LANTUS SOLOSTAR 178 165 29 93
LOSARTAN POTASSIUM 177 149 30 17
FENTANYL 161 134 S2 31 78
TAMSULOSIN HCL 157 156 32 23
CRESTOR 139 97 33 25
AZITHROMYCIN 136 110 34 45
LANTUS 131 120 35 47
TRAZODONE HCL 130 86 36 61
DIOVAN 128 121 37 29
PLAVIX 125 98 38 43
CELEBREX 124 115 39 99
NOVOLOG FLEXPEN 122 115 40 205
SERTRALINE HCL 119 118 41 26
RANITIDINE HCL 117 85 42 37
NEXIUM 115 87 43 41
GLIPIZIDE ER 114 114 44 73
MIRTAZAPINE 111 102 45 63
ADVAIR DISKUS 107 63 46 48
ALENDRONATE SODIUM 105 92 47 21
NITROGLYCERIN PATCH 100 100 48 149
ESCITALOPRAM OXALATE 98 98 49 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 88 50 127
MELOXICAM 94 53 51 51
SINGULAIR 93 63 52 94
KLOR-CON M20 93 80 52 52
PRAMIPEXOLE DIHYDROCHLORIDE 88 84 54 188
PANTOPRAZOLE SODIUM 85 67 55 28
ROPINIROLE HCL 82 70 56 113
FAMOTIDINE 81 81 57 36
PAROXETINE HCL 80 63 58 71
SPIRIVA 80 65 58 56
GLIMEPIRIDE 79 63 60 39
IPRATROPIUM-ALBUTEROL 79 78 60 104
FLUTICASONE PROPIONATE 77 61 62 40
DIVALPROEX SODIUM 73 38 63 89
JANUVIA 73 62 63 60
HUMALOG 72 56 65 141
INSULIN SYRINGE 72 56 65 81
LIPITOR 68 50 67 114
DIPHENOXYLATE-ATROPINE 65 63 68 331
DIGOXIN 64 64 69 38
ALBUTEROL SULFATE 64 64 69 116
NOVOLOG 63 58 71 103
NYSTOP 63 62 71 242
NITROFURANTOIN MONO-MACRO 61 58 73 234
LYRICA 61 39 73 100
ESTRADIOL 60 48 R 75 344
LEVOFLOXACIN 59 54 76 77
CARBIDOPA-LEVODOPA 57 57 77 83
FENOFIBRATE 57 45 77 64
LOVASTATIN 56 52 79 34
BUSPIRONE HCL 56 35 79 173
NAPROXEN 55 42 81 95
LEVETIRACETAM 53 0 82 90
NYSTATIN 52 48 83 196
PROAIR HFA 52 13 83 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.